蓝帆医疗:SoniCracker™-CL获NMPA注册证,Lithonic™通过欧盟CE认证,2026年启动海外销售并快速放量

Core Viewpoint - The company, Bluestar Medical, announced significant advancements in its product development, specifically the SoniCracker™-CL catheter and the Lithonic™ system, which are expected to enhance its market position in the medical device industry [1] Group 1: Product Development - The SoniCracker™-CL, a disposable intravascular shockwave catheter, is set to receive the medical device registration certificate from NMPA in 2024 [1] - The Lithonic™ intravascular shockwave therapy system is anticipated to obtain CE certification in January 2026, enabling the company to initiate overseas sales shortly thereafter [1] - The company expects rapid market penetration and sales growth for the Lithonic™ system following its certification [1]

BLUE SAIL MEDICAL-蓝帆医疗:SoniCracker™-CL获NMPA注册证,Lithonic™通过欧盟CE认证,2026年启动海外销售并快速放量 - Reportify